53.31000 USD
0.32
0.60%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
52.58000
53.33000
Previous close
52.99000
Open
53.049999
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
53.31
0.32
0.60%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 776.1M 825.4M 745.1M 747.3M
Cost of revenue 140.1M 150.1M 151.6M 136.1M
Gross profit 636.0M 675.3M 593.6M 611.2M
Operating expense
Research & development 409.5M 161.3M 158.7M 173.5M
Selling general and admin 268.4M 232.3M 206.1M 266.6M
Other operating expenses
Operating income -46.7M 276.9M 223.9M 161.4M
Non operating interest income
Income 17.9M 18.8M 19.0M 17.7M
Expense 2.6M 2.7M 2.9M 2.3M
Other income expense 5.1M 4.8M -2.0M -6.9M
Pretax income -26.3M 297.9M 238.1M 169.6M
Tax provision 4.4M 57.3M 52.4M 44.7M
Net income -30.7M 240.5M 185.7M 124.9M
Basic EPS -0.2 1.3 1.0 0.7
Diluted EPS -0.2 1.2 1.0 0.6
Basic average shares 192.0M 191.9M 191.0M 190.7M
Diluted average shares 192.0M 197.1M 196.5M 196.6M
EBITDA -5.3M 319.1M 263.0M 195.5M
Net income from continuing op. -30.7M 240.5M 185.7M 124.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 15 hours 14 minutes

12:45
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).